Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerability and safety of Oxamet in acute rhinitis
2004-002276-42Phase 4Completed
- Sponsor
- IVAX
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of oxymetazoline in nasopharyngitis, sponsored by IVAX. Primary endpoint: Assessment of symptoms. Started Nov 2004; status: completed.
02
Drugs
oxymetazoline
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on 2004-002276-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002276-42.